Growth Metrics

Apellis Pharmaceuticals (APLS) Short-Term Debt repayments (2024)

Apellis Pharmaceuticals (APLS) has 1 years of Short-Term Debt repayments data on record, last reported at $5.6 million in Q4 2024.